References
- Tuckuviene R, Christensen AL, Helgestad J, et al. Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis in Denmark 1994–2006: a nationwide population-based study. Acta Paediatr. 2011;100:543–549.
- Marlar RA, Gausman JN. Laboratory testing issues for protein C, protein S, and antithrombin. Int J Lab Hematol. 2014;36:289–295.
- Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in patients homozygous for factor V leiden (activated protein C resistance). Blood. 1995;85:1504–1508.
- Kenet G, Lütkhoff L, Albisetti M, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation. 2010;121:1838–1847.
- Young G, Albisetti M, Bonduel M, et al. Impact of inherited thrombophilia on venous thromboembolism in children. Circulation. 2008;118:1373–1382.
- Shaheen K, Alraies MC, Alraiyes AH, et al. Factor V leiden: how great is the risk of venous thromboembolism? Cleve Clin J Med. 2012;79:265–272.
- Andrew M, Michelson AD, Bovill T, et al. The prevention and treatment of thromboembolic disease in children: a need for thrombophilia programs. J Pediatr Hematol Oncol. 1997;19:7–22.
- Sode BF, Allin KH, Dahl M, et al. Risk of venous thromboembolism and myocardial infarction associated with factor V leiden and prothrombin mutations and blood type. CMAJ. 2013;185:E229–E237.
- Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 1994;87:106–112.
- Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost. 1995;73:87–93.
- Dykes AC, Walker ID, McMahon AD, et al. A study of protein S antigen levels in 3788 healthy volunteers: Influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol. 2001;113:636–641.
- Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood. 1992;80:1998–2005.
- Urbanus RT, Siegerink B, Roest M, et al. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol. 2009;8:998–1005.
- Whitcombe D, Brownie J, Gillard HL, et al. A homogeneous fluorescence assay for PCR amplicons: its application to real-time, single-tube genotyping. Clin Chem. 1998;44:918–923.
- Monagle P, Barnes C, Ignjatovic V, et al. Developmental haemostasis, impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95:362–372.
- Toulon P, Berruyer M, Brionne-Francois M, et al. Age dependency for coagulation parameters in paediatric populations. Results of a multicentre study aimed at defining the age-specific reference ranges. Thromb Haemost. 2016;116:9–16.
- Tuckuviene R, Christensen AL, Helgestad J, et al. Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. J Pediatr. 2011;159:663–669.
- Tormene D, Simioni Prandoni P, et al. The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood. 2002;100:2403–2405.
- Tromboser hos børn; Diagnostik og antitrombotisk behandling. [Thromboembolisms i children; Diagnosis and antithrombotic treatment] (assessed 8th September 2018). http://www.paediatri.dk/images/dokumenter/Vejledninger_2016/Trombose_hos_boern_030216.pdf
- Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149:209–220.
- Chalmers E, Ganesen V, Liesner R, et al. Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol. 2011;154:196–207.